Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.1616
+0.0034
+(2.15%)
At close: March 6 at 3:29:01 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
151,259
151,259
215,734
183,629
163,832
Operating Income
-151,259
-151,259
-215,734
-183,629
-163,832
Net Non Operating Interest Income Expense
11,032
11,032
26,497
8,663
2,729
Pretax Income
-212,712
-212,712
-189,239
-167,792
-164,722
Tax Provision
-11,651
-11,651
--
--
--
Net Income Common Stockholders
-201,061
-201,061
-189,239
-167,792
-164,722
Diluted NI Available to Com Stockholders
-201,061
-201,061
-189,239
-167,792
-164,722
Basic EPS
-5.80
--
-5.50
-4.90
-5.10
Diluted EPS
-5.80
--
-5.50
-4.90
-5.10
Basic Average Shares
34,406
--
34,398
34,247
32,373
Diluted Average Shares
34,406
--
34,398
34,247
32,373
Total Operating Income as Reported
-223,744
-223,744
-215,736
-183,631
-163,832
Rent Expense Supplemental
4,594
4,594
4,874
4,221
3,645
Total Expenses
151,259
151,259
215,734
183,629
163,832
Net Income from Continuing & Discontinued Operation
-201,061
-201,061
-189,239
-167,792
-164,722
Normalized Income
-60,057.3733
-60,057.3733
-189,239
-172,845
-163,244
Interest Income
12,417
12,417
29,640
8,906
3,062
Interest Expense
1,385
1,385
3,143
--
333
Net Interest Income
11,032
11,032
26,497
8,663
2,729
EBIT
-211,327
-211,327
-186,096
-183,629
-163,832
EBITDA
-208,558
-208,558
-183,328
-180,981
-161,129
Reconciled Depreciation
2,769
2,769
2,768
2,648
2,703
Net Income from Continuing Operation Net Minority Interest
-201,061
-201,061
-189,239
-167,792
-164,722
Total Unusual Items Excluding Goodwill
-72,487
-72,487
--
5,053
-1,478
Total Unusual Items
--
--
--
5,053
-1,478
Normalized EBITDA
-208,558
-208,558
-183,328
-186,034
-159,651
Tax Rate for Calcs
0.0001
0.0001
--
--
--
Tax Effect of Unusual Items
-3,970.3733
-3,970.3733
--
--
--
12/31/2021 - 6/5/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
50BA.F Bicycle Therapeutics plc
9.65
0.00%
471A.F aTyr Pharma, Inc.
2.9000
+1.40%
0M4.F Mersana Therapeutics, Inc.
0.4302
+1.63%
EX9.F Exelixis, Inc.
35.75
-0.17%
22Z.F Zealand Pharma A/S
72.55
-3.46%
4YL.F Nanoform Finland Oyj
1.0700
-5.31%
SOFTX.OL SoftOx Solutions AS
0.0360
+0.56%
RVMDW Revolution Medicines, Inc.
0.0734
0.00%
RVMD Revolution Medicines, Inc.
39.22
-1.01%
PDSB PDS Biotechnology Corporation
1.3400
+2.29%